EA200971077A1 - Гетероциклические модуляторы киназы - Google Patents
Гетероциклические модуляторы киназыInfo
- Publication number
- EA200971077A1 EA200971077A1 EA200971077A EA200971077A EA200971077A1 EA 200971077 A1 EA200971077 A1 EA 200971077A1 EA 200971077 A EA200971077 A EA 200971077A EA 200971077 A EA200971077 A EA 200971077A EA 200971077 A1 EA200971077 A1 EA 200971077A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- kinase modulators
- heterocyclic kinase
- heterocyclic
- modulators
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
В настоящем изобретении предложены гетероциклические модуляторы протеинкиназы и способы применения указанных соединений для лечения заболеваний, опосредуемых киназной активностью.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93931307P | 2007-05-21 | 2007-05-21 | |
PCT/US2008/064437 WO2008144767A1 (en) | 2007-05-21 | 2008-05-21 | Heterocyclic kinase modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200971077A1 true EA200971077A1 (ru) | 2010-04-30 |
Family
ID=40122219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200971077A EA200971077A1 (ru) | 2007-05-21 | 2008-05-21 | Гетероциклические модуляторы киназы |
Country Status (11)
Country | Link |
---|---|
US (1) | US20090156594A1 (ru) |
EP (1) | EP2162132A4 (ru) |
JP (1) | JP2010528991A (ru) |
KR (1) | KR101156845B1 (ru) |
CN (1) | CN101678014B (ru) |
AU (1) | AU2008254588B2 (ru) |
BR (1) | BRPI0812360A2 (ru) |
CA (1) | CA2688823A1 (ru) |
EA (1) | EA200971077A1 (ru) |
MX (1) | MX2009012623A (ru) |
WO (1) | WO2008144767A1 (ru) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2660836A1 (en) | 2006-08-07 | 2008-02-21 | Incyte Corporation | Triazolotriazines as kinase inhibitors |
EP2099447B1 (en) | 2006-11-22 | 2012-11-07 | Incyte Corporation | Imidazotriazines and imidazopyrimidines as kinase inhibitors |
ES2548768T3 (es) | 2007-09-27 | 2015-10-20 | Fundación Centro Nacional De Investigaciones Oncológicas Carlos Iii | Imidazolotiadiazoles para su uso como inhibidores de proteína quinasa |
WO2009143211A2 (en) | 2008-05-21 | 2009-11-26 | Incyte Corporation | Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same |
RU2011124894A (ru) | 2008-11-19 | 2012-12-27 | Вертекс Фармасьютикалз Инкорпорейтед | Триазолотиадиазоловый ингибитор протеинкиназы с-мет |
DK2414369T3 (en) | 2009-04-02 | 2015-09-21 | Fundacion Ct Nac Investigaciones Oncologicas Carlos Iii | Imidazo [2,1-b] [1,3,4] thiadiazole derivatives |
JP2012528185A (ja) * | 2009-05-28 | 2012-11-12 | バーテックス ファーマシューティカルズ インコーポレイテッド | c−Metタンパク質キナーゼの置換ピラゾール阻害剤 |
CN102448969A (zh) * | 2009-05-28 | 2012-05-09 | 沃泰克斯药物股份有限公司 | C-met蛋白激酶抑制剂 |
ES2433090T3 (es) * | 2009-05-28 | 2013-12-09 | Vertex Pharmaceuticals Incorporated | Inhibidores a base de aminopirazol triazolotiadiazol de la proteína cinasa c-met |
AU2010283806A1 (en) | 2009-08-12 | 2012-03-01 | Novartis Ag | Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation |
JP5775871B2 (ja) | 2009-08-20 | 2015-09-09 | ノバルティス アーゲー | ヘテロ環式オキシム化合物 |
US8343977B2 (en) | 2009-12-30 | 2013-01-01 | Arqule, Inc. | Substituted triazolo-pyrimidine compounds |
CN102812027B (zh) | 2010-02-03 | 2015-01-07 | 因西特公司 | 作为C-MET抑制剂的咪唑并[1,2-b][1,2,4]三嗪 |
JP2013527195A (ja) * | 2010-05-27 | 2013-06-27 | バーテックス ファーマシューティカルズ インコーポレイテッド | c−Metプロテインキナーゼのアミノピラゾールトリアゾロチアジアゾールインヒビター |
WO2012003338A1 (en) | 2010-07-01 | 2012-01-05 | Takeda Pharmaceutical Company Limited | COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET |
CN103204862B (zh) * | 2012-01-12 | 2014-12-17 | 清华大学深圳研究生院 | 6-苯基咪唑并[2,1-b]噻唑-3-酰胺类衍生物及其制备方法与应用 |
CN103204822B (zh) | 2012-01-17 | 2014-12-03 | 上海科州药物研发有限公司 | 作为蛋白激酶抑制剂的苯并噁唑化合物及其制备方法和用途 |
AU2013269800A1 (en) * | 2012-05-30 | 2014-10-09 | F. Hoffmann-La Roche Ag | Triazolo compounds as PDE10 inhibitors |
EP2682395A1 (en) | 2012-07-04 | 2014-01-08 | Laboratorios Del. Dr. Esteve, S.A. | Imidazo[2,1-b]thiazole derivatives, their preparation and use as medicaments |
CN105209453B (zh) | 2012-10-16 | 2017-06-20 | 詹森药业有限公司 | ROR‑γ‑T的亚甲基连接的喹啉基调节剂 |
CN104884448A (zh) | 2012-10-16 | 2015-09-02 | 詹森药业有限公司 | Rorγt的杂芳基连接的喹啉基调节剂 |
SG11201502935VA (en) | 2012-10-16 | 2015-09-29 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of ror-gamma-t |
JP2016503395A (ja) | 2012-10-31 | 2016-02-04 | バイエル・クロップサイエンス・アクチェンゲゼルシャフト | 病害生物防除剤としての複素環化合物 |
CN103833771A (zh) * | 2012-11-22 | 2014-06-04 | 天津滨江药物研发有限公司 | 作为蛋白激酶Mek抑制剂的苯并五元杂环化合物及其制备方法和用途 |
CN103073491A (zh) * | 2013-01-25 | 2013-05-01 | 桑迪亚医药技术(上海)有限责任公司 | 一种2-(5,7-二氟-6-喹啉基)乙酸/丙酸(酯)的合成方法 |
US9328095B2 (en) | 2013-10-15 | 2016-05-03 | Janssen Pharmaceutica Nv | Heteroaryl linked quinolinyl modulators of RORgammat |
US9284308B2 (en) | 2013-10-15 | 2016-03-15 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of RORγt |
US9221804B2 (en) | 2013-10-15 | 2015-12-29 | Janssen Pharmaceutica Nv | Secondary alcohol quinolinyl modulators of RORγt |
US10555941B2 (en) | 2013-10-15 | 2020-02-11 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORγt |
US9403816B2 (en) | 2013-10-15 | 2016-08-02 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of RORγt |
US9624225B2 (en) | 2013-10-15 | 2017-04-18 | Janssen Pharmaceutica Nv | Quinolinyl modulators of RORγt |
CA2926339A1 (en) | 2013-10-15 | 2015-04-23 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of roryt |
US10398774B2 (en) | 2014-12-09 | 2019-09-03 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Human monoclonal antibodies against AXL |
WO2016135041A1 (en) | 2015-02-26 | 2016-09-01 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Fusion proteins and antibodies comprising thereof for promoting apoptosis |
GR1009565B (el) * | 2016-07-14 | 2019-08-06 | Galenica Α.Ε. | Νεα παραγωγα 1,2,4-τριαζολο-[3,4-b]-1,3,4-θειαδιαζολιων |
ES2896331T3 (es) * | 2017-07-10 | 2022-02-24 | UCB Biopharma SRL | Derivados del 2-oxo-1,3-oxazolidinilimidazotiadiazol |
CN109897054B (zh) * | 2017-12-08 | 2021-12-10 | 中国药科大学 | 三唑并噻二唑类c-Met激酶抑制剂的制备方法及其用途 |
MX2020011275A (es) | 2018-04-25 | 2020-11-13 | Bayer Ag | Novedosos compuestos de heteroaril-triazol y hetroaril[-]tetrazol como plaguicidas. |
EP3805234B1 (en) * | 2018-05-24 | 2024-09-04 | Guangzhou Henovcom Bioscience Co., Ltd. | Aromatic heterocyclic compound, and pharmaceutical composition and use thereof |
KR20220038402A (ko) | 2019-07-23 | 2022-03-28 | 바이엘 악티엔게젤샤프트 | 살충제로서의 신규 헤테로아릴-트리아졸 화합물 |
UY38796A (es) | 2019-07-23 | 2021-02-26 | Bayer Ag | Novedosos compuestos de heteroaril-triazol como plaguicidas |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3050583A (en) * | 1958-10-07 | 1962-08-21 | Stephens Trusonic Inc | Controllable stereophonic electroacoustic network |
GB9416162D0 (en) * | 1994-08-10 | 1994-09-28 | Merck Sharp & Dohme | Therapeutic agents |
GB9918035D0 (en) * | 1999-07-30 | 1999-09-29 | Novartis Ag | Organic compounds |
TW200301251A (en) * | 2001-12-20 | 2003-07-01 | Wyeth Corp | Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
UA78999C2 (en) * | 2002-06-04 | 2007-05-10 | Wyeth Corp | 1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6 |
TW200403243A (en) * | 2002-07-18 | 2004-03-01 | Wyeth Corp | 1-Heterocyclylalkyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
EP1554272B1 (en) * | 2002-08-09 | 2006-10-25 | Eli Lilly And Company | Benzimidazoles and benzothiazoles as inhibitors of map kinase |
AU2003298942A1 (en) * | 2002-12-11 | 2004-06-30 | Merck And Co., Inc. | Tyrosine kinase inhibitors |
PA8595001A1 (es) * | 2003-03-04 | 2004-09-28 | Pfizer Prod Inc | Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transforante (tgf) |
GB0405055D0 (en) * | 2004-03-05 | 2004-04-07 | Eisai London Res Lab Ltd | JNK inhibitors |
DE602005027825D1 (de) * | 2004-03-30 | 2011-06-16 | Vertex Pharma | Als inhibitoren von jak und anderen proteinkinasen geeignete azaindole |
US7439246B2 (en) * | 2004-06-28 | 2008-10-21 | Bristol-Myers Squibb Company | Fused heterocyclic kinase inhibitors |
US7432373B2 (en) * | 2004-06-28 | 2008-10-07 | Bristol-Meyers Squibb Company | Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors |
US7361764B2 (en) * | 2004-07-27 | 2008-04-22 | Sgx Pharmaceuticals, Inc. | Pyrrolo-pyridine kinase modulators |
EP1781654A1 (en) * | 2004-07-27 | 2007-05-09 | SGX Pharmaceuticals, Inc. | Pyrrolo-pyridine kinase modulators |
AU2005269387A1 (en) * | 2004-07-27 | 2006-02-09 | Sgx Pharmaceuticals, Inc. | Fused ring heterocycle kinase modulators |
CA2584368A1 (en) * | 2004-10-19 | 2006-04-27 | Arqule, Inc. | Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase |
FR2890072A1 (fr) * | 2005-09-01 | 2007-03-02 | Fournier S A Sa Lab | Nouveaux composesde pyrrolopyridine |
EP2298770A1 (en) * | 2005-11-03 | 2011-03-23 | ChemBridge Corporation | Heterocyclic compounds as TrkA modulators |
EP1963329B1 (en) * | 2005-11-30 | 2013-01-23 | Vertex Pharmaceuticals Incorporated | Inhibitors of c-met and uses thereof |
-
2008
- 2008-05-21 CA CA2688823A patent/CA2688823A1/en not_active Abandoned
- 2008-05-21 WO PCT/US2008/064437 patent/WO2008144767A1/en active Application Filing
- 2008-05-21 BR BRPI0812360-8A2A patent/BRPI0812360A2/pt not_active IP Right Cessation
- 2008-05-21 US US12/124,988 patent/US20090156594A1/en not_active Abandoned
- 2008-05-21 EA EA200971077A patent/EA200971077A1/ru unknown
- 2008-05-21 AU AU2008254588A patent/AU2008254588B2/en not_active Ceased
- 2008-05-21 KR KR1020097024189A patent/KR101156845B1/ko not_active IP Right Cessation
- 2008-05-21 EP EP08769573A patent/EP2162132A4/en not_active Withdrawn
- 2008-05-21 CN CN2008800169794A patent/CN101678014B/zh not_active Expired - Fee Related
- 2008-05-21 JP JP2010509541A patent/JP2010528991A/ja active Pending
- 2008-05-21 MX MX2009012623A patent/MX2009012623A/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CN101678014A (zh) | 2010-03-24 |
US20090156594A1 (en) | 2009-06-18 |
KR20090130212A (ko) | 2009-12-18 |
BRPI0812360A2 (pt) | 2015-01-27 |
EP2162132A4 (en) | 2013-01-16 |
AU2008254588A1 (en) | 2008-11-27 |
KR101156845B1 (ko) | 2012-06-18 |
JP2010528991A (ja) | 2010-08-26 |
WO2008144767A1 (en) | 2008-11-27 |
AU2008254588B2 (en) | 2013-01-17 |
EP2162132A1 (en) | 2010-03-17 |
MX2009012623A (es) | 2009-12-11 |
CA2688823A1 (en) | 2008-11-27 |
CN101678014B (zh) | 2012-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200971077A1 (ru) | Гетероциклические модуляторы киназы | |
EA200970403A1 (ru) | Бициклические триазолы в качестве модуляторов протеинкиназы | |
EA200970402A1 (ru) | Триазолопиридазиновые модуляторы протеинкиназ | |
EA200901157A1 (ru) | Конденсированные кольцевые гетероциклические модуляторы киназы | |
NO20070908L (no) | Sammensmeltede ringheterocykelkinasemodulatorer | |
EA200970738A1 (ru) | Ингибиторы активности akt | |
EA201170349A1 (ru) | Модуляторы mif | |
NO20083002L (no) | Fremgangsmate for anvendelse av CD40-bindende forbindelser | |
TW200745109A (en) | Pyrrolo-pyridine kinase modulators | |
EA200901313A1 (ru) | Ингибиторы тирозинкиназы брутона | |
EA201790267A1 (ru) | Новые модуляторы киназ | |
EA201001329A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
EA201071089A1 (ru) | Производные хиназолина как модуляторы raf-киназы и способы их применения | |
EA201001331A1 (ru) | ГЕТЕРОЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ И СОДЕРЖАЩИЕ ИХ КОМПОЗИЦИИ В КАЧЕСТВЕ ИНГИБИТОРОВ КИНАЗ c-kit И PDGFR | |
EA200901166A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr 119 | |
TNSN07027A1 (en) | Pyrrolo-pyridine kinase modulators | |
EA200900959A1 (ru) | Ингибиторы мек | |
WO2008124849A3 (en) | Pyrrolo-pyridine kinase modulators | |
EA200901032A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
NO20082476L (no) | Bicykliske forbindelser med kinaseinhiberende aktivitet | |
EA201001332A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
EA201290255A1 (ru) | Способы и композиции для лечения рака | |
EA200901486A1 (ru) | СОЕДИНЕНИЯ И КОМПОЗИЦИИ, КАК ИНГИБИТОРЫ КИНАЗЫ c-KIT И PDGFR | |
EA201290103A1 (ru) | Гетероциклические соединения и их использование | |
PH12015501955B1 (en) | Heterocyclic compounds and use thereof as modulators of type iii receptor tyrosine kinases |